Taurus Asset Management’s Boston Scientific BSX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q1 | $1.01M | Hold |
10,000
| – | – | 0.1% | 56 |
|
|
2024
Q4 | $893K | Hold |
10,000
| – | – | 0.09% | 59 |
|
|
2024
Q3 | $838K | Hold |
10,000
| – | – | 0.08% | 59 |
|
|
2024
Q2 | $770K | Hold |
10,000
| – | – | 0.08% | 59 |
|
|
2024
Q1 | $685K | Sell |
10,000
-1,675
| -14% | -$108K | 0.07% | 61 |
|
|
2023
Q4 | $675K | Sell |
11,675
-1,500
| -11% | -$80.1K | 0.07% | 61 |
|
|
2023
Q3 | $696K | Hold |
13,175
| – | – | 0.08% | 56 |
|
|
2023
Q2 | $713K | Sell |
13,175
-4,500
| -25% | -$235K | 0.08% | 58 |
|
|
2023
Q1 | $884K | Sell |
17,675
-225
| -1% | -$10.6K | 0.11% | 54 |
|
|
2022
Q4 | $828K | Hold |
17,900
| – | – | 0.11% | 54 |
|
|
2022
Q3 | $693K | Hold |
17,900
| – | – | 0.09% | 53 |
|
|
2022
Q2 | $667K | Sell |
17,900
-4,728
| -21% | -$192K | 0.08% | 56 |
|
|
2022
Q1 | $1M | Sell |
22,628
-544,544
| -96% | -$23.6M | 0.1% | 50 |
|
|
2021
Q4 | $24.1M | Buy |
567,172
+5,625
| +1% | +$236K | 2.27% | 18 |
|
|
2021
Q3 | $24.4M | Sell |
561,547
-13,716
| -2% | -$607K | 2.54% | 14 |
|
|
2021
Q2 | $24.6M | Sell |
575,263
-100,700
| -15% | -$4.24M | 2.57% | 14 |
|
|
2021
Q1 | $26.1M | Sell |
675,963
-725
| -0.1% | -$27.4K | 3.02% | 11 |
|
|
2020
Q4 | $24.3M | Buy |
676,688
+255
| +0% | +$9.19K | 2.91% | 11 |
|
|
2020
Q3 | $25.8M | Sell |
676,433
-3,075
| -0.5% | -$118K | 3.2% | 8 |
|
|
2020
Q2 | $23.9M | Sell |
679,508
-2,065
| -0.3% | -$74.4K | 3.31% | 8 |
|
|
2020
Q1 | $22.2M | Buy |
681,573
+185,595
| +37% | +$7.25M | 3.69% | 8 |
|
|
2019
Q4 | $22.4M | Sell |
495,978
-4,975
| -1% | -$208K | 2.92% | 9 |
|
|
2019
Q3 | $20.4M | Sell |
500,953
-75,712
| -13% | -$3.21M | 2.9% | 14 |
|
|
2019
Q2 | $24.8M | Buy |
576,665
+86,850
| +18% | +$3.34M | 3.38% | 8 |
|
|
2019
Q1 | $18.8M | Sell |
489,815
-9,050
| -2% | -$346K | 2.63% | 14 |
|
|
2018
Q4 | $17.6M | Buy |
498,865
+1,300
| +0.3% | +$47.1K | 2.82% | 12 |
|
|
2018
Q3 | $19.2M | Sell |
497,565
-111,020
| -18% | -$3.88M | 2.59% | 11 |
|
|
2018
Q2 | $19.9M | Sell |
608,585
-1,525
| -0.2% | -$46K | 2.91% | 9 |
|
|
2018
Q1 | $16.7M | Buy |
610,110
+17,325
| +3% | +$471K | 2.51% | 12 |
|
|
2017
Q4 | $14.7M | Buy |
592,785
+208,435
| +54% | +$5.75M | 2.16% | 14 |
|
|
2017
Q3 | $11.2M | Sell |
384,350
-4,500
| -1% | -$124K | 1.74% | 27 |
|
|
2017
Q2 | $10.8M | Sell |
388,850
-100
| -0% | -$2.65K | 1.69% | 26 |
|
|
2017
Q1 | $9.67M | Buy |
+388,950
| New | +$9.46M | 1.59% | 29 |
|
Other funds holding BSX
Taurus Asset Management's BSX Position: Q1 2025 in Review
Taurus Asset Management held its Boston Scientific (BSX) position steady in Q1 2025 at 10,000 shares worth $1.01M. The position accounts for 0.1% of the portfolio, ranked #56.
Taurus Asset Management first reported a position in BSX in Q1 2017 and has held it in 33 quarters since. The position peaked at $26.1M in Q1 2021. 1,644 funds tracked by Wall St. Rank hold BSX as of Q1 2025.
- Taurus Asset Management held 10,000 shares of Boston Scientific worth $1.01M as of Q1 2025.
- Taurus Asset Management left its Boston Scientific share count unchanged in Q1 2025.
- Boston Scientific made up 0.1% of Taurus Asset Management's portfolio in Q1 2025, its #56 holding.
- Taurus Asset Management first reported a position in Boston Scientific in Q1 2017 and has held it in 33 quarters since.
- Taurus Asset Management's Boston Scientific position peaked at $26.1M in Q1 2021.
- 1,644 funds tracked by Wall St. Rank held Boston Scientific as of Q1 2025.
Based on Taurus Asset Management's 13F filing for Q1 2025, filed 13 May 2025.